Adam Lam

Adam Lam

Auto-generated profile, based on publicly available information

Adam Lam

Department of Anesthesiology and Perioperative Medicine, Division of Molecular and Translational Biomedicine

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2018 in JCI Insight
Verified
Journal Article
Open access
PDF file
SASaurabh Aggarwal
Saurabh Aggarwal
IAIsrar Ahmad
Israr Ahmad
ALAdam Lam
Adam Lam
MCMatthew A. Carlisle
Matthew A. Carlisle
CLChangzhao Li
Changzhao Li
SMSadis Matalon
Sadis Matalon
Pulmonary fibrosis and emphysema are irreversible chronic events after inhalation injury. However, the mechanism(s) involved in their development remain poorly understood. Higher levels of plasma and lung heme have been recorded in acute lung injury associated with several insults. Here, we provide the molecular basis for heme-induced chronic lung injury. We found elevated plasma heme in chronic obstructive pulmonary disease (COPD) (GOLD stage 4) patients and also in a ferret model of COPD secondary to chronic cigarette smoke inhalation. Next, we developed a rodent model of chronic lung injury, where we exposed C57BL/6 mice to the halogen gas, bromine (Br 2 ) (400 ppm, 30 minutes), and returned them to room air resulting in combined airway fibrosis and emphysematous phenotype, as indicated by high collagen deposition in the peribronchial spaces, increased lung hydroxyproline concentrations, and alveolar septal damage. These mice also had elevated pulmonary endoplasmic reticulum (ER) stress as seen in COPD patients; the pharmacological or genetic diminution of ER stress in mice attenuated Br 2 -induced lung changes. Finally, treating mice with the heme-scavenging protein, hemopexin, reduced plasma heme, ER stress, airway fibrosis, and emphysema. This is the first study to our knowledge to report elevated heme in COPD patients and establishes heme scavenging as a potential therapy after inhalation injury.

1 July 2018 in Journal of Surgical Research
Verified
Journal Article
Closed access
ALAdam Lam
Adam Lam
MHMartin J. Heslin
Martin J. Heslin
CTChing-Wei D. Tzeng
Ching-Wei D. Tzeng
HCHerbert Chen
Herbert Chen

16 November 2012 in Blood
Verified
Journal Article
Open access
RBRena Buckstein
Rena Buckstein
SAShabbir Alibhai
Shabbir Alibhai
DKDina Khalaf
Dina Khalaf
ALAdam Lam
Adam Lam
AMAlex Mamedov
Alex Mamedov
RWRichard A. Wells
Richard A. Wells
Abstract 699

4 January 2023 in Annals of Thoracic Surgery Short Reports
Verified
Journal Article
Open access
ALAdam Lam
Adam Lam
NCNicholas P. Campbell
Nicholas P. Campbell
HRHyde M. Russell
Hyde M. Russell
SKSeth B. Krantz
Seth B. Krantz
We present a case of an advanced squamous cell carcinoma encroaching on a patient’s left internal mammary artery bypass graft. Tumor board consensus was to proceed with 2 cycles of neoadjuvant chemotherapy followed by resection. Intraoperatively, the left internal mammary artery bypass could not be safely dissected from the adjacent pleura, but frozen sections were negative for malignant transformation. Final pathologic examination showed a complete pathologic response to neoadjuvant chemotherapy, and surveillance imaging is now negative for recurrence 5 years postoperatively. Although malignant neoplasms invading into adjacent vasculature can post technical challenges during an operation, neoadjuvant therapy can downstage these tumors and make resection feasible without added morbidity.